• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Angina Market Size

    ID: MRFR/Pharma/4293-HCR
    90 Pages
    Rahul Gotadki
    October 2025

    Angina Market Research Report, by Type (Angina Pectoris), Diagnosis (Imaging, Stress Test), Treatment (Lifestyle, Medications, Angioplasty, and Stenting), End-Users (Hospital & Clinics, Diagnostic Centers, Academic Institutes)–Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Angina Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Angina Size

    Angina Market Growth Projections and Opportunities

    Angina, a side effect of coronary artery disease (CAD), influences a huge piece of the population around the world, especially people beyond 45 years old, with frequency rates expanding with age and changing across various socioeconomics and geological districts. The angina market is impacted by a scope of treatment choices, including drugs, for example, dynamite, beta-blockers, calcium station blockers, and antiplatelet specialists, as well as revascularization techniques like percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG), pointed toward freeing side effects and diminishing the risk from cardiovascular occasions. Factors, for example, age, orientation, lifestyle propensities, family background of computer aided design, comorbidities like hypertension, diabetes, and robustness, impact the predominance and seriousness of angina, affecting market elements as far as tolerant pool size and treatment interest. Varieties in medical services framework, admittance to cardiology subject matter experts, accessibility of symptomatic offices, and reasonableness of therapy choices add to variations in the angina market across various districts and medical care frameworks. The degree of health care coverage inclusion, repayment arrangements, and personal costs impact patients' admittance to angina medicines and cardiovascular administrations, in this way molding market elements and treatment usage designs. The angina therapy market is described by serious elements with numerous drug organizations, clinical gadget makers, and medical care suppliers competing for market share through item development, marketing techniques, and estimating. Worldwide trade arrangements, duties, and administrative harmonization endeavors influence the accessibility, evaluating, and market access of angina medicines on a worldwide scale, impacting market elements and rivalry among market players. Changing buyer inclinations, patterns towards customized medication, expanded emphasis on preventive cardiology, and patient inclinations for specific treatment modalities influence market interest for angina medicines and impact item improvement methodologies.

    Angina Market Size Graph

    Market Summary

    As per Market Research Future Analysis, the Global Angina Market was valued at USD 0.52 Billion in 2023 and is projected to grow to USD 2.13 Billion by 2032, with a CAGR of 5.52% from 2024 to 2032. Angina, a symptom of coronary artery disease, is characterized by chest pain due to reduced blood flow to the heart. The market growth is driven by the increasing prevalence of angina, rising healthcare expenditure, and a growing geriatric and obese population. However, challenges such as low per capita healthcare expenditure and high costs of therapeutic procedures may restrain growth. Recent developments include Auxilius Pharma's upcoming Phase Ib trial for AUX-001 and Zydus Lifesciences' approval for Isosorbide Mononitrate extended-release tablets.

    Key Market Trends & Highlights

    The angina market is witnessing significant developments and growth opportunities.

    • Market Size in 2023: USD 0.52 Billion.
    • Projected Market Size by 2032: USD 2.13 Billion.
    • CAGR from 2024 to 2032: 5.52%.
    • Prevalence of angina in West Virginia: 6.2%.

    Market Size & Forecast

    2023 Market Size USD 0.52 Billion
    2024 Market Size USD 0.72 Billion
    2032 Market Size USD 2.13 Billion
    CAGR (2024-2032) 5.52%.

    Major Players

    Anthera (U.S.), Taxus Cardium (U.S.), Astellas Pharma (Japan), Sanofi (France), Bayer AG (Germany), Merck & Co., Inc. (U.S.), Torrent Pharmaceuticals Limited (India), Huya Bioscience International (U.S.), Viromed Co. Ltd. (South Korea), Baxter (U.S.)

    Market Trends

    The increasing prevalence of cardiovascular diseases globally suggests a rising demand for effective angina management solutions, highlighting the need for innovative therapeutic approaches.

    World Health Organization (WHO)

    Angina Market Market Drivers

    Aging Population

    The demographic shift towards an aging population is a significant factor impacting the Global Global Angina Market Industry. Older adults are at a higher risk for developing cardiovascular diseases, including angina, due to age-related physiological changes. As the global population ages, particularly in developed nations, the demand for angina-related healthcare services and products is expected to rise. This demographic trend suggests a sustained increase in market size, as healthcare systems adapt to meet the needs of this growing patient demographic.

    Market Growth Projections

    The Global Global Angina Market Industry is projected to witness substantial growth over the coming years. With an estimated market value of 0.72 USD Billion in 2024, it is expected to expand to 2.5 USD Billion by 2035. This growth trajectory indicates a compound annual growth rate of 11.99% from 2025 to 2035, reflecting the increasing demand for effective angina treatments and management solutions. The market's expansion is likely to be fueled by various factors, including advancements in medical technology, rising prevalence of cardiovascular diseases, and supportive regulatory frameworks.

    Growing Awareness and Education

    There is a notable increase in awareness and education regarding cardiovascular health, which is influencing the Global Global Angina Market Industry. Public health campaigns and educational initiatives are effectively informing individuals about the symptoms and risks associated with angina. This heightened awareness encourages early diagnosis and treatment, thereby driving market growth. As more patients seek medical advice upon experiencing symptoms, healthcare providers are prompted to offer a wider range of treatment options, further expanding the market's potential.

    Advancements in Medical Technology

    Technological innovations in medical devices and pharmaceuticals are propelling the Global Global Angina Market Industry forward. New diagnostic tools and treatment options, such as advanced stents and drug-eluting technologies, enhance patient outcomes and improve the management of angina. These advancements not only facilitate early detection but also enable more personalized treatment approaches. As healthcare systems worldwide adopt these technologies, the market is likely to experience substantial growth, driven by the increasing availability of effective therapies that cater to diverse patient needs.

    Regulatory Support and Initiatives

    Government initiatives and regulatory support play a crucial role in shaping the Global Global Angina Market Industry. Policies aimed at improving cardiovascular health and funding for research into new treatments are fostering an environment conducive to market growth. Regulatory bodies are increasingly approving innovative therapies and devices, which enhances treatment options available to patients. This supportive regulatory landscape is likely to encourage investment in research and development, further driving advancements in angina management.

    Rising Prevalence of Cardiovascular Diseases

    The increasing incidence of cardiovascular diseases globally is a primary driver of the Global Global Angina Market Industry. As lifestyle-related factors such as poor diet, lack of physical activity, and rising obesity rates contribute to heart conditions, the demand for angina management solutions intensifies. In 2024, the market is projected to reach 0.72 USD Billion, reflecting the urgent need for effective treatments. This trend is expected to continue, with the market anticipated to grow significantly, potentially reaching 2.5 USD Billion by 2035, indicating a robust compound annual growth rate of 11.99% from 2025 to 2035.

    Market Segment Insights

    Regional Insights

    Key Companies in the Angina Market market include

    Industry Developments

    Future Outlook

    Angina Market Future Outlook

    The Global Angina Market is projected to grow at 11.99% CAGR from 2024 to 2035, driven by advancements in treatment options, increasing prevalence, and enhanced patient awareness.

    New opportunities lie in:

    • Develop innovative telehealth solutions for remote angina management.
    • Invest in research for novel pharmacological therapies targeting angina symptoms.
    • Expand distribution networks in emerging markets to increase access to angina treatments.

    By 2035, the Global Angina Market is expected to exhibit robust growth, reflecting significant advancements and increased market penetration.

    Market Segmentation

    Global Angina Market Segmentation

    Key Players in the Angina Market
    • Anthera (U.S.)
    • Taxus Cardium (U.S.)
    • Astellas Pharma (Japan)
    • Sanofi (France)
    • Bayer AG (Germany)
    • ., Inc. (U.S.)
    • Torrent Pharmaceuticals Limited (India)
    • Huya Bioscience International (U.S.)
    • Viromed Co. Ltd. (South Korea)
    • Baxter (U.S.)

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 0.52 (USD Billion)
    Market Size 2024 0.72 (USD Billion)
    Market Size 2032 2.13 (USD Billion)
    Compound Annual Growth Rate (CAGR) 5.52 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
     
     
    Forecast Units   Value (USD Billion)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Types, end user, Region
    Geographies Covered America, Europe, Asia Pacific, Middle East and Africa
    Key Vendors Anthera (U.S.), Taxus Cardium (U.S.), Astellas Pharma (Japan), Sanofi (France), Bayer AG (Germany), Merck & Co., Inc. (U.S.), Torrent Pharmaceuticals Limited (India), Huya Bioscience International (U.S.), Viromed Co. Ltd. (South Korea), Baxter (U.S.)

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    What is Angina?

    Angina is a significant symptom of coronary artery disease and can be described as squeezing, tightness, and heaviness of the chest. It is a type of chest pain caused by a reduced flow of blood to the heart.

    What is the CAGR of the Angina Market?

    Global Angina Market is expected to exhibit a strong 5.52% CAGR over the forecast period till 2032.

    What is the major driver for the Angina Market?

    The growing prevalence of cardiovascular diseases is the major driver for the global angina market.

    Which is the major regional Angina Market?

    The Americas dominate the Global Angina Market.

    What are the key players in the Angina Market?

    Leading players in the Angina Market include Bayer AG, Sanofi, and Astellas Pharma, among others.

    1. TABLE OF CONTENT    
    2. Chapter 1.    Report Prologue    
    3. Chapter 2.    Market Introduction    
      1.     Definition    
      2.     Scope of the Study    
        1.     Research Objective    
        2.     Assumptions    
        3.     Limitations    
    4. Chapter 3.    Research Methodology
      1.     Introduction
      2.     Primary Research    
      3.     Secondary research    
      4.     Market Size Estimation
    5. Chapter 4.    Market Dynamics
      1.     Drivers    
      2.     Restrains
      3.     Opportunities    
      4.     Challenges
      5.     Macroeconomic Indicators
      6.     Technology Trends & Assessment            
    6. Chapter 5.    Market Factor Analysis
      1.     Porter’s Five Forces Analysis
        1.     Bargaining Power of Suppliers    
        2.     Bargaining Power of Buyers
        3.     Threat of New Entrants    
        4.     Threat of Substitutes    
        5.     Intensity of Rivalry    
      2.     Value Chain Analysis
      3.     Investment Feasibility Analysis    
      4.     Pricing Analysis
    7. Chapter 6.    Global Angina Market, by Type
    8.      6.1    Introduction
      1.     Angina Pectoris
    9. Market Estimates & Forecast, 2020–2027
      1.     Unstable Angina
      2.     Prinzmetal Angina
      3.     Others
    10. Chapter 7.    Global Angina Market, by Diagnosis
    11.      7.1    Introduction
      1.     Imaging
    12. Market Estimates & Forecast, 2020–2027 
      1.     Electrocardiogram
        1.     Chest X-ray
        2.     Cardiac Computerized Tomography Scan
        3.     Cardiac MRI
        4.     Others
      2.     Blood Tests
        1.     Cholesterol Test
        2.     Low-Density Lipoprotein Test
        3.     Triglycerides Test
        4.     Others
      3.     Stress Test
      4.     Others
    13. Chapter 8.    Global Angina Market, by Treatment
      1.     Introduction
      2.     Lifestyle Changes
      3.     Medications
        1.     Aspirin
        2.     Clot-Preventing Drugs
    14. Market Estimates & Forecast, 2020–2027
      1.     Clopidogrel
        1.     Prasugrel
        2.     Statins
        3.     Ranolazine
        4.     Others
      2.     Angioplasty and Stenting 
      3.     Coronary Bypass Surgery
    15. Market Estimates & Forecast, 2020–2027
      1.     Others
    16. Chapter 9.    Global Angina Market, by End-User
      1.     Introduction
      2.     Hospital & Clinics
      3.     Diagnostic Centers
      4.     Academic Institutes
      5.     Others
    17. Chapter 10.    Global Angina Market, by Region
      1.     Introduction
      2.     America
        1.     North America
        2.     South America
      3.     Europe
        1.     Western Europe
        2.     Eastern Europe
      4.     Asia Pacific
        1.     Japan
        2.     China
        3.     India
        4.     Australia
        5.     Republic of Korea
        6.     Rest of Asia Pacific
      5.     The Middle East & Africa 
        1.     United Arab Emirates
        2.     Saudi Arabia
        3.     Oman
        4.     Kuwait
        5.     Qatar
        6.     Rest of the Middle East & Africa 
    18. Chapter 11.    Company Landscape    
      1.     Introduction    
      2.     Market Share Analysis    
      3.     Key Development & Strategies    
        1.     Key Developments    
    19. Chapter 12    Company Profiles    
      1.     Anthera
        1.     Company Overview    
        2.     Type Overview    
        3.     Financials
        4.     Key Developments    
        5.     SWOT Analysis    
      2.     Taxus Cardium
        1.     Company Overview    
        2.     Type Overview    
        3.     Financial Overview    
        4.     Key Developments    
        5.     SWOT Analysis    
      3.     Astellas Pharma
        1.     Company Overview    
        2.     Type Overview    
        3.     Financial Overview
        4.     Key Development    
        5.     SWOT Analysis    
      4.     Sanofi
        1.     Company Overview    
        2.     Type/Business Segment Overview    
        3.     Financial Overview    
        4.     Key Development    
        5.     SWOT Analysis    
      5.     Bayer AG 
        1.     Company Overview    
        2.     Type Overview    
        3.     Financial overview    
        4.     Key Developments    
        5.     SWOT Analysis    
      6.     Merck & Co., Inc.
        1.     Company Overview    
        2.     Type Overview    
        3.     Financial Overview    
        4.     Key Developments    
        5.     SWOT Analysis    
      7.     Torrent Pharmaceuticals
        1.     Overview    
        2.     Type Overview    
        3.     Financials    
        4.     Key Developments    
        5.     SWOT Analysis    
    20.     12.8    Huya Bioscience International
      1.     Overview    
        1.     Type Overview    
        2.     Financials    
        3.     Key Developments    
        4.     SWOT Analysis    
      2.     Viromed Co. Ltd.
        1.     Overview    
        2.     Type Overview    
        3.     Financials    
        4.     Key Developments    
        5.     SWOT Analysis    
      3.     Baxter
        1.     Overview    
        2.     Type Overview    
        3.     Financials    
        4.     Key Developments    
        5.     SWOT Analysis    
      4.     Others
    21. Chapter 13    MRFR Conclusion    
      1.     Key Findings    
        1.     From CEO’s View Point    
        2.     Unmet Needs of the Market    
      2.     Key Companies to Watch    
      3.     Prediction of Angina Market
    22. Chapter 14    Appendix
    23. List of Tables and Figures
      1. LIST OF TABLES
      2. Table 1        Angina Industry Synopsis, 2020–2027
      3. Table 2        Global Angina Market Estimates & Forecast, 2020–2027, (USD Million)
      4. Table 3        Global Angina Market, by Region, 2020–2027, (USD Million)
      5. Table 4        Global Angina Market, by Type, 2020–2027, (USD Million)
      6. Table 5        Global Angina Market, by Diagnosis, 2020–2027, (USD Million)
      7. Table 6        Global Angina Market, by Treatment, 2020–2027, (USD Million)
      8. Table 7        Global Angina Market, by End-User, 2020–2027, (USD Million
      9. Table 8        North America Angina Market, by Type, 2020–2027, (USD Million)
      10. Table 9        North America Angina, by Diagnosis, 2020–2027, (USD Million)
      11. Table 10    North America Angina, by Treatment, 2020–2027, (USD Million)
      12. Table 11    North America Angina, by End-User, 2020–2027, (USD Million)
      13. Table 12    U.S. Angina Market, by Type, 2020–2027, (USD Million)
      14. Table 13    U.S. Angina Market, by Diagnosis, 2020–2027, (USD Million)
      15. Table 14    U.S. Angina Market, by Treatment, 2020–2027, (USD Million)
      16. Table 15    U.S. Angina Market, by End-User, 2020–2027, (USD Million)
      17. Table 16    Canada Angina Market, by Type, 2020–2027, (USD Million)
      18. Table 17    Canada Angina Market, by Diagnosis, 2020–2027, (USD Million)
      19. Table 18    Canada Angina Market, by Treatment, 2020–2027, (USD Million)
      20. Table 19    Canada Angina Market, by End-User, 2020–2027, (USD Million)
      21. Table 20    South America Angina Market, by Type, 2020–2027, (USD Million)
      22. Table 21    South America Angina Market, by Diagnosis, 2020–2027, (USD Million)
      23. Table 22    South America Angina Market, by Treatment, 2020–2027, (USD Million)
      24. Table 23    South America Angina Market, by End-User, 2020–2027, (USD Million)
      25. Table 24    Europe Angina Market, by Type, 2020–2027, (USD Million)
      26. Table 25    Europe Angina Market, by Diagnosis, 2020–2027, (USD Million)
      27. Table 26    Europe Angina Market, by Treatment, 2020–2027, (USD Million)
      28. Table 27    Europe Angina Market, by End-User, 2020–2027, (USD Million)
      29. Table 28    Western Europe Angina Market, by Type, 2020–2027, (USD Million)
      30. Table 29    Western Europe Angina Market, by Diagnosis, 2020–2027, (USD Million)
      31. Table 30    Western Europe Angina Market, by Treatment, 2020–2027, (USD Million)
      32. Table 31    Western Europe Angina Market, by End-User, 2020–2027, (USD Million)
      33. Table 32    Eastern Europe Angina Market, by Type, 2020–2027, (USD Million)
      34. Table 33    Eastern Europe Angina Market, by Diagnosis, 2020–2027, (USD Million)
      35. Table 34    Eastern Europe Angina Market, by Treatment, 2020–2027, (USD Million)
      36. Table 35    Eastern Europe Angina Market, by End-User, 2020–2027, (USD Million)
      37. Table 36    Asia Pacific Angina Market, by Type, 2020–2027, (USD Million)
      38. Table 37    Asia Pacific Angina Market, by Diagnosis, 2020–2027, (USD Million)
      39. Table 38    Asia Pacific Angina Market, by Treatment, 2020–2027, (USD Million)
      40. Table 39    Asia Pacific Angina Market, by End-User, 2020–2027, (USD Million)
      41. Table 40    The Middle East & Africa Angina Market, by Type, 2020–2027, (USD Million)
      42. Table 41    The Middle East & Africa Angina Market, by Diagnosis, 2020–2027, (USD Million)
      43. Table 42    The Middle East & Africa Angina Market, by Treatment, 2020–2027, (USD Million)
      44. Table 43    The Middle East & Africa Angina Market, by End-User, 2020–2027, (USD Million) LIST OF FIGURES
      45. Figure 1    Research Process
      46. Figure 2    Segmentation for Global Angina Market
      47. Figure 3    Market Dynamics for Global Angina Market
      48. Figure 4    Global Angina Market Share, by Type 2020
      49. Figure 5    Global Angina Market Share, by Diagnosis 2020
      50. Figure 6    Global Angina Market Share, by Treatment, 2020
      51. Figure 7    Global Angina Market Share, by End-User, 2020
      52. Figure 8    Global Angina Market Share, by Region, 2020
      53. Figure 9    North America Angina Market Share, by Country, 2020
      54. Figure 10    Europe Angina Market Share, by Country, 2020
      55. Figure 11    Asia Pacific Angina Market Share, by Country, 2020
      56. Figure 12    The Middle East & Africa Angina Market Share, by Country, 2020
      57. Figure 13    Global Angina Market: Company Share Analysis, 2020 (%)
      58. Figure 14    Anthera: Key Financials
      59. Figure 15    Anthera: Segmental Revenue
      60. Figure 16    Anthera: Geographical Revenue
      61. Figure 17    Taxus Cardium: Key Financials
      62. Figure 18    Taxus Cardium: Segmental Revenue
      63. Figure 19    Taxus Cardium: Geographical Revenue
      64. Figure 20    Astellas Pharma: Key Financials
      65. Figure 21    Astellas Pharma: Segmental Revenue
      66. Figure 22    Astellas Pharma: Geographical Revenue
      67. Figure 23    Sanofi: Key Financials
      68. Figure 24    Sanofi: Segmental Revenue
      69. Figure 25    Sanofi: Geographical Revenue
      70. Figure 26    Bayer AG: Key Financials
      71. Figure 27    Bayer AG: Segmental Revenue
      72. Figure 28    Bayer AG: Geographical Revenue
      73. Figure 29    Merck & Co., Inc.: Key Financials
      74. Figure 30    Merck & Co., Inc.: Segmental Revenue
      75. Figure 31    Merck & Co., Inc.: Geographical Revenue
      76. Figure 32    Torrent Pharmaceuticals Limited: Key Financials
      77. Figure 33    Torrent Pharmaceuticals Limited: Segmental Revenue
      78. Figure 34    Torrent Pharmaceuticals Limited: Geographical Revenue
      79. Figure 35    Huya Bioscience International: Key Financials
      80. Figure 36    Huya Bioscience International: Segmental Revenue
      81. Figure 37    Huya Bioscience International: Geographical Revenue
      82. Figure 38    Viromed Co. Ltd.: Key Financials
      83. Figure 39    Viromed Co. Ltd.: Segmental Revenue
      84. Figure 40    Viromed Co. Ltd.: Geographical Revenue
      85. Figure 41    Baxter: Key Financials
      86. Figure 42    Baxter: Segmental Revenue
      87. Figure 43    Baxter: Geographical Revenue    

    Angina Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials